Justin Hart, MD
Radiation Oncology · Charlotte, NCNPI 1316263353
Payments from drug & device makers
Across 30 payments — averaging $21.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$99
- AstraZeneca$86
- Pharmacyclics LLC, An Abbvie Company$71
- Seagen Inc.$64
- Boehringer Ingelheim$45
- Merck$39
- plus $235 from 12 others
What the payments were for
- Food & beverage$638100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 5 | $99 |
| AstraZeneca | 2 | $86 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $71 |
| Seagen Inc. | 4 | $64 |
| Boehringer Ingelheim | 2 | $45 |
| Merck | 2 | $39 |
| Ambu Inc. | 1 | $30 |
| Siemens Medical Solutions USA, Inc. | 1 | $26 |
| Bayer | 1 | $23 |
| GSK | 1 | $22 |
| Amgen | 1 | $22 |
| Morphosys, US Inc. | 1 | $19 |
| Angiodynamics, Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Pfizer | 1 | $16 |
| Array Biopharma Inc | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Taiho Oncology, Inc. | 1 | $13 |
How this compares
$638 in reported general payments places this provider in the 55th percentile of 199 radiation oncology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Silver Sulfadiazine | 11 | $133 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Charlotte
- John HeinzerlingCharlotte$2.4M
- Stuart BurriCharlotte$17K
- Lamar McGinnisCharlotte$15K
- Michael LecompteCharlotte$9K
- Roshan PrabhuCharlotte$6K
- Matthew WardCharlotte$3K
- David KirschDurham$6.2M
- Colette ShenChapel Hill$4.7M
- Lewis SulmanDurham$3.9M
- Manisha PaltaDurham$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.